Director of the Foundation
Mara-Jean is the Director of the marketing and fundraising arm of the Garvan Institute of Medical Research. Formerly the Director of Philanthropy, Bequests and Campaigns, Mara-Jean commenced working at Garvan in 2011. Prior to joining Garvan, Mara-Jean was the Foundation Executive at the Sydney Theatre Company where she held a variety of positions over more than 8 years with the organisation. Mara-Jean is a member of the Perpetual Foundation and Centenary Foundation Advisory Committee.
Brad commenced with the Foundation in 2016 as Head of Fundraising and was then Director of Fundraising, Marketing and Communications prior to his current role. Before joining Garvan he was National Events Manager at Cancer Council Australia for 4 years and has held marketing and fundraising related roles with some of Australia’s best known charities, including Red Cross and the Heart Foundation.
FOUNDATION BOARD OF DIRECTORS
The Garvan Research Foundation Board was established in 1981. The Foundation provides an additional source of research funds by attracting financial support from companies and individuals. The Board is subject to the ultimate direction of the Garvan Institute Board.
Russell Scrimshaw – Chair
Mr Scrimshaw is the Garvan Research Foundation Board Chair. He is also Non-Executive Chairman of Sirius Minerals Plc, Non-Executive Chairman of Tech Project Group P/L and the Executive Chairman of Torrus Capital P/L, the Australian Philanthropic Fund, the Scrimshaw Foundation and Scrimshaw Nominees P/L. Previously, he held executive positions at Fortescue Metals Group Ltd (FMG), Commonwealth Bank, Optus and IBM. He was also a non- executive Board Director for Genome.One P/L, Commonwealth Properties Ltd, EDS Australia, Mobilesoft Ltd, Telecom New Zealand Australia P/L, and Athletics Australia. Mr Scrimshaw is a non-executive Director of the Garvan Institute.
Chris Goodnow is an internationally renowned immunologist. He joined Garvan in 2015 as Deputy Director, the Bill & Patricia Ritchie Foundation Chair, and head of the Immunogenomics Laboratory. Chris has had an extensive international research career. He has been a faculty member at Stanford University and the Australian National University, and has been closely involved in several biotechnology start-up companies. He is best known for discovering immune tolerance checkpoints by integrating molecular genetics and genomics with immunology, for which he received numerous awards and election to the Australian Academy of Science, the UK Royal Society, and the US National Academy of Science.
Mr Abrahams is the Global Head of Technology and Innovation at Norton Rose Fulbright and has deep commercial expertise and global networks in the technology space. He is the Founder of leading online legal site, LawPath. He is a non-executive director on ASX300 software company, Integrated Research. He is a director of the Sydney Film Festival and is on the board of the Vodafone Foundation, and past President of the Australian Communications and Media Law Association and writes regularly on technology and future trends for The Australian Financial Review. He is the author of two Kindle Business books: Digital Disruption in Australia and Big Data, Big Responsibilities: A Guide to Privacy & Data Security for Australian Business.
Ms Allen is a founding Partner of Maritana Partners, a specialist Governance Advisory business. Previously she was a Managing Partner at Egon Zehnder in Australia, where she also held a leadership role across Asia Pacific. A member of Chief Executive Women, Ms Allen has an MBA from Harvard Business School and a Bachelor of Arts from Smith College. She is also a Director of the American Australian Association Limited, which promotes cooperation and understanding between the United States and Australia.
Mr Cannon-Brookes is a Director of Cannon-Brookes Consulting Pty Ltd, and a CEO level executive coach with Foresight Global Coaching. He established Citibank in Australia in 1985. He retired from IBM in July 2012, where he was IBM’s Vice President, Global Strategy for Growth Markets, based in Shanghai, China. Mr Cannon-Brookes, a UK citizen, took Australian citizenship in 1994. He graduated with Honors in Law from Cambridge University. He was elected a Global Board Member of Advance in 2013, and in the same year a Fellow of the Australian Institute of Company Directors.
Ms McCabe is the Head of Lifestyle for nine.com.au at Nine Entertainment Co. Prior to this she was Editor-in-Chief at the The Australian Women’s Weekly, Deputy Editor of The Sunday Telegraph, Night Editor of The Australian and held key roles on The Daily Telegraph. She is also on the board of the Australian Indigenous Education Fund and an Ambassador for Adopt Change. Ms McCabe is Digital Content Director at Nine Entertainment Co. Prior to this she was Editor-in-Chief at The Australian Women’s Weekly, Deputy Editor of The Sunday Telegraph, Night Editor of The Australian and held key roles on The Daily Telegraph. She is also the founding director of Future Women. She is also on the board of the Australian Indigenous Education Fund and an Ambassador for Adopt Change.
Mr McLennan is a media and marketing industry executive
with over 30 years of experience. He is Chairman of REA Group, Chairman of HT&E and a non- executive director of Magellan Financial group. He was Executive Chairman and Chief Executive Officer of Ten Network Holdings until July 2015 and prior to this he was Executive Vice President, Office of the Chairman, at News Corp (formerly News Corporation). Mr McLennan has also held the role of global Chairman of Young & Rubicam, part of WPP, the world’s largest communications services group. In 2017, he joined technology start-up Tiger Pistol in an advisory capacity. He has previously served on the Board of Directors for the United Negro College Fund (UNCF) and the US Ad Council.
Simon Mordant AM
Mr Mordant is Executive Co- Chairman of Luminis Partners. He is also the Chair of the Museum of Contemporary Art Australia and Lend Lease Barangaroo Public Art Committee, a board member of the Museum of Contemporary Art in Los Angeles, MOMA PS1 in New York, Wharton Executive Board in Asia, a Trustee of the American Academy in Rome and a member of the Executive Committee of Tate International Council and a member of the International Council of the Museum of Modern Art in New York.
John Schubert AO
Dr Schubert is Chairman of the Garvan Institute of Medical Research, Chairman of the Great Barrier Reef Foundation, and a director of the Garvan Research Foundation Board. He has held positions as Chairman of the Commonwealth Bank of Australia, non-executive director of BHP Billiton Limited, BHP Billiton Plc, and Qantas Airways Limited, Chief Executive Officer of Pioneer International Limited, Chairman of WorleyParsons Limited and G2 Therapies Ltd, Chairman and MD of Esso Australia Ltd, and non-executive director of Hanson Plc.
Dr Strong graduated in Medicine, practicing in occupational and preventative medicine; has a postgraduate degree in Applied Finance and Investment, BA (literature), was on the Board of Bluearth, flew her Beechcraft Baron from California to Australia via Europe, and races Etchells yachts including recent wins in the Australasian, Queensland and Victorian state championships.
Peter Young, AM
Mr Young is currently a Principal for The Adelante Group, a Board member of the Barangaroo Delivery Authority Board, and a member of the Barangaroo Arts and Cultural Panel. He was previously Chairman of Standard Life Investments Australia and subsequently Aberdeen Standard Investments Australia, Chairman of Barclays Australia, Chairman of the Queensland Investment Corporation (QIC), Chairman of the Transfield Services Infrastructure Fund, and Chairman of the Board of the Australian Federal Government-owned Export Finance and Insurance Corporation (EFIC). He is a former Non-Executive Director of Fairfax Media, the Sydney Theatre Company, PrimeAg Australia, a Trustee of NSW Art Gallery, and subsequently a Trustee of the Queensland Art Gallery, and a member of the Board of the Great Barrier Reef Foundation. He is a recipient of the Australian Federal Government’s Centenary Medal and in 2008 was appointed a Member of the Order of Australia (AM) for his services to business and commerce.